These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 7006614
21. Immunosuppressive therapy in the rheumatic diseases. Can Med Assoc J; 1971 Dec 04; 105(11):1125-6. PubMed ID: 4948506 [No Abstract] [Full Text] [Related]
23. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort. González-Echavarri C, Capdevila O, Espinosa G, Suárez S, Marín-Ballvé A, González-León R, Rodríguez-Carballeira M, Fonseca-Aizpuru E, Pinilla B, Pallarés L, Ruiz-Irastorza G, RELES, Autoimmune Diseases Study Group GEAS. Lupus; 2018 Dec 04; 27(14):2253-2261. PubMed ID: 30451641 [Abstract] [Full Text] [Related]
25. Cyclophosphamide in lupus nephritis: a controlled trial. Steinberg AD, Kaltreider HB, Staples PJ, Goetzl EJ, Talal N, Decker JL. Ann Intern Med; 1971 Aug 04; 75(2):165-71. PubMed ID: 4104337 [No Abstract] [Full Text] [Related]
26. Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical, histological, and immunological changes with therapy. Drinkard JP, Stanley TM, Dornfeld L, Austin RC, Barnett EV, Pearson CM, Vernier RL, Adams DA, Latta H, Gonick HC. Medicine (Baltimore); 1970 Sep 04; 49(5):411-32. PubMed ID: 4924695 [No Abstract] [Full Text] [Related]
27. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus]. Małdykowa H, Chwalińska-Sadowska H, Grabowska A, Dratwianka B, Abgarowicz-Miłkowska T, Jedryka-Góral A, Swierczyńska Z, Rdułtowska H, Luft S, Rogozińska E. Reumatologia; 1982 Sep 04; 20(1-2):7-14. PubMed ID: 7163667 [No Abstract] [Full Text] [Related]
32. Pramipexole and ropinirole for Parkinson's disease. Med Lett Drugs Ther; 1997 Nov 21; 39(1014):109-10. PubMed ID: 9398824 [No Abstract] [Full Text] [Related]
33. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone. Gonzalez-Echavarri C, Pernas B, Ugarte A, Ruiz-Irastorza G. Lupus; 2014 Mar 21; 23(3):323-6. PubMed ID: 24531426 [Abstract] [Full Text] [Related]
34. Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus. Schiffenbauer J, Hahn B, Weisman MH, Simon LS. Arthritis Rheum; 2004 Aug 21; 50(8):2415-22. PubMed ID: 15334452 [No Abstract] [Full Text] [Related]
35. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. Carneiro JR, Sato EI. J Rheumatol; 1999 Jun 21; 26(6):1275-9. PubMed ID: 10381042 [Abstract] [Full Text] [Related]
38. Development of hypogammaglobulinemia in a patient with systemic lupus erythematosus. Tsokos GC, Smith PL, Balow JE. Am J Med; 1986 Dec 21; 81(6):1081-4. PubMed ID: 3541592 [Abstract] [Full Text] [Related]
39. Intravenous cyclophosphamide therapy of severe SLE. McCune WJ, Fox D. Rheum Dis Clin North Am; 1989 Aug 21; 15(3):455-77. PubMed ID: 2672132 [Abstract] [Full Text] [Related]
40. [Effect of combined immunosuppressive treatment with Imuran and prednisone on the concentration of selected immune proteins in the serum of patients with lupus erythematosus]. Chwal Z. Pol Tyg Lek; 1976 May 19; 31(16):659-61. PubMed ID: 1083976 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]